Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-03-01 @ 11:27 AM
Study NCT ID:
NCT02682420
Status:
TERMINATED
Last Update Posted:
2025-12-11
First Post:
2016-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
everlinQ endoAVF Post Market Study
Sponsor:
C. R. Bard
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CD-0018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None